logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5317.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5317.produseast1
Conference Material
|Slide Presentation

Operational feasibility and acceptability of the addition of R21 malaria vaccine and intermittent preventive therapy for children to existing malaria control initiatives in Kule, Ethiopia

Girma Y, Lavilla KM, Tassawar A, Siferaw K, Koang D, Tugizimana D, Dirks A, Assefa G, Ayalew M, Loonen JACM, Ariti C, Mapiye G, Mulanda W, de Lima Pereira A, Bestman A, Velivela K, Rao B, Stringer B, Wilson R, Abbara A, Keating P
Download
Similar Content
Abstract
|Abstract
Operational feasibility and acceptability of the addition of R21 malaria vaccine and intermittent preventive therapy for children to existing malaria control initiatives in Kule, Ethiopia
2025 May 22 • MSF Scientific Days International 2025
Loading...
Loading...
No abstract available

Countries

Ethiopia

Subject Area

vaccinationpediatricsmalaria

Languages

English
Published Date
22 May 2025
Conference
MSF Scientific Days International 2025
Linked Content
Conference Material
|Abstract
Operational feasibility and acceptability of the addition of R21 malaria vaccine and intermittent preventive therapy for children to existing malaria control initiatives in Kule, Ethiopia
2025 May 22 • MSF Scientific Days International 2025
Operational feasibility and acceptability of the addition of R21 malaria vaccine and intermittent preventive therapy for children to existing malaria control initiatives in Kule, Ethiopia | Conference Material / Slide Presentation | MSF Science Portal